Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism.

Neuropsychopharmacology  – July 21, 2023

Source: PubMed Central

Summary

Carefully monitored psychedelic treatments show remarkable potential in addressing mental health conditions like depression, PTSD, and addiction. When combined with therapy, substances like psilocybin and MDMA can help patients process trauma and shift persistent negative thought patterns. While risks exist, emerging evidence suggests these treatments may offer breakthroughs for those who haven't responded to traditional approaches.

Abstract

Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism.

Comments

No comments yet.

Log in to comment